PMV Pharmaceuticals (PMVP) Payables (2019 - 2026)
PMV Pharmaceuticals (PMVP) reported Payables of $2.02 million for Q2 2026, down 22.2% from $2.6 million a year earlier but up 23.9% from the prior quarter.
PMV Pharmaceuticals (PMVP) Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, PMV Pharmaceuticals posted Payables of $3.16 million, down 52.0% from FY2024.
- Payables has a five-year compound annual growth rate of 14.4% (FY2020 to FY2025).
- By year, Payables came in at $6.58 million in FY2024 (+103.2%), $3.24 million in FY2023 (+8.0%), $3 million in FY2022 (-6.1%) and $3.19 million in FY2021 (+98.4%).
- Five-year quarterly Payables spans a low of $859,000 in Q1 2024 and a high of $6.58 million in Q4 2024.
- Year over year, Payables has now declined in each of the last three quarters, with growth averaging 42.2% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q1 2025 (growth of 318.3%); the low point was Q3 2023 (a decline of 65.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.63 million (Q1 2026), $3.16 million (Q4 2025) and $3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | PMV Pharmaceuticals | 72.71 Mn | -342.47 Mn | - | 2.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.02 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 3.16 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 3.59 Mn |
| Dec 31, 2024 | 6.58 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 4.53 Mn |
| Mar 31, 2024 | 859,000.00 |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 1.77 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 4.83 Mn |
| Jun 30, 2022 | 3.35 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 3.19 Mn |
| Sep 30, 2021 | 1.28 Mn |
PMV Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PMVP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PMVP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PMVP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();